MedPath

A clinical trial to evaluate the safety and efficacy of high-definition transcranial direct current stimulation (HD-tDCS) to improve cognitive flexibility and emotional self-regulation in young people with autism spectrum disorder

Not Applicable
Completed
Conditions
Autism Spectrum Disorders
Mental Health - Autistic spectrum disorders
Registration Number
ACTRN12616001045404
Lead Sponsor
Deakin University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
12
Inclusion Criteria

Right and left handed individuals with a diagnosis of autism spectrum disorder with mild intellectual ability or higher (IQ>55).
Stable medication regime for at least 4 weeks, and stable throughout duration of enrolment in study.

Exclusion Criteria

-Participants whose primary language is other than English.
- Pregnant women.
- Participants <16 years old.
- Participants with metal implants in their heads.
- Major medical or neurological condition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath